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Preface 
 
Gliomas are the most common intrinsic brain tumors. They can occur in any age 
group and any location of the central nervous system and cause major morbidity and 
mortality. Glioblastoma, the most common variant of glioma, is among the most lethal 
cancers across oncology. In the clinic, advances in neurosurgical techniques, 
increased safety and tolerability of radiotherapy and advanced neuroimaging have 
improved care and outcome on a population level in recent years. Although 
therapeutic measures for most gliomas are still not curative today, major advances in 
the understanding of the pathogenesis and molecular genetic alterations 
characterizing gliomas have had a major impact on the development of novel 
experimental treatments. 
 
We have joined forces in co-editing the present volume of the Handbook of Clinical 
Neurology as representatives of the neurosurgery and medical neuro-oncology 
approaches to gliomas. Our goal is to provide an update on all relevant areas of the 
disease glioma, thus providing a comprehensive reference. 
 
All chapters are written by international leaders in the field, partnering experts from 
the US/Canada and Europe across the entire volume, often coauthored by junior 
members of our research community. General chapters on diagnosis and treatment 
of gliomas are followed by a second part of general chapters addressing 
complications and symptomatic management. Finally, the third part includes disease 
specific chapters on the various types of glioma. We are grateful to all authors for 
devoting their time and effort to make this a unique source of knowledge in one of the 
most active research fields in neuro-oncology. 
 
 
M. Berger         M. Weller 
 
